WILLIAM LOUIS MACIAS, M.D.
Osteopathic Medicine at Log Run Dr, Indianapolis, IN
License number
Indiana 01037069A
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
9129 Log Run Dr S, Indianapolis, IN 46234
Phone
(317) 291-7862
Personal information
See more information about WILLIAM LOUIS MACIAS at radaris.comName
Address
Phone
9129 Log Run Dr S, Indianapolis, IN 46234
Indianapolis, IN
1001 10Th St, Indianapolis, IN 46202
1120 South St, Indianapolis, IN 46202
9129 Log Run Dr, Indianapolis, IN 46234
Professional information
Dr. William L Macias, Indianapolis IN - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Nephrology
Address:
Lilly Corporate Ctr, Indianapolis 46285
Certifications:
Critical Care Medicine, 1991, Internal Medicine, 1986, Nephrology, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Indiana University / School of Medicine
Graduated: 1983
Indiana University / School of Medicine
Graduated: 1983
Senior Medical Director At Eli Lilly And Company
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Spla2 Inhibitor Compounds For Treatment Of Disease
US Patent:
6340699, Jan 22, 2002
Filed:
Apr 20, 1999
Appl. No.:
09/673675
Inventors:
William Louis Macias - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3140
US Classification:
514419
Abstract:
The present invention is directed to compounds for treating inflammatory bowel disease. More specifically, the present invention is directed to 1H-indole-3-glyoxyamide compounds a sPLA inhibitors for treating inflammatory bowel disease.
Method For Treatment Of Non-Rheumatoid Arthritis
US Patent:
6610728, Aug 26, 2003
Filed:
Feb 24, 2000
Appl. No.:
09/486472
Inventors:
William Louis Macias - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3140
US Classification:
514419, 514415, 514416
Abstract:
A method is disclosed for the treatment of non-rheumatoid arthritis by administering to a mammal in need thereof a therapeutically effective amount of an sPLA inhibitor.
Method For The Treatment Of Cystic Fibrosis
US Patent:
6576654, Jun 10, 2003
Filed:
Mar 8, 2000
Appl. No.:
09/508209
Inventors:
William Louis Macias - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31405
US Classification:
514415, 514851
Abstract:
A method is disclosed for the treatment of cystic fibrosis by administering to a human in need thereof a therapeutically effective amount of an sPLA inhibitor, such as a 1H-indole-3-glyoxylamide.
Method For Treatment Of Chronic Bronchitis Using Indole Compounds
US Patent:
5972988, Oct 26, 1999
Filed:
Mar 12, 1998
Appl. No.:
9/042686
Inventors:
William Louis Macias - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31405
US Classification:
514415
Abstract:
A method is disclosed for the treatment of chronic bronchitis by administering to a mammal in need thereof a therapeutically effective amount of a 1H-indole-3-glyoxylamide compound.
Combination Therapy For The Treatment Of Inflammatory And Respiratory Diseases
US Patent:
2002019, Dec 26, 2002
Filed:
Jun 7, 2002
Appl. No.:
10/149366
Inventors:
William Macias - Indianapolis IN, US
International Classification:
A61K038/17, A61K031/22
US Classification:
514/002000, 514/546000
Abstract:
A pharmaceutical composition for the treatment of Inflammatory Disease or Respiratory Disease in mammals, which comprises, as active ingredients, a neutrophil elastase inhibitor and Activated Protein C.
Method For The Treatment Of Renal Dysfunction With Spla2 Inhibitors
US Patent:
2003008, May 8, 2003
Filed:
Aug 5, 2002
Appl. No.:
10/203436
Inventors:
William Macias - Indianapolis IN, US
Vincent Meador - Greenfield IN, US
Vincent Meador - Greenfield IN, US
International Classification:
A61K031/403, A61K031/415, A61K031/405, A61K031/40, A61K031/165
US Classification:
514/406000, 514/411000, 514/408000, 514/419000, 514/617000
Abstract:
A method is disclosed for the treatment of of the symptoms associated with renal dysfunction by administering to an animal in need thereof a therapeutically effective amount of a sPLAinhibitor, such as a 1H-indole-3-glyoxylamide.
Combination Therapy For The Treatment Of Inflammatory And Respiratory Diseases
US Patent:
2003009, May 15, 2003
Filed:
Jun 7, 2002
Appl. No.:
10/149365
Inventors:
William Macias - Indianapolis IN, US
International Classification:
A61K031/22
US Classification:
514/546000
Abstract:
A pharmaceutical composition for the treatment of Inflammatory Disease or Respiratory Disease in mammals, which comprises, as active ingredients, a neutrophil elastase inhibitor and an sPLAinhibitor.
Method For Treating Sepsis
US Patent:
2004011, Jun 10, 2004
Filed:
Jan 3, 2003
Appl. No.:
10/332178
Inventors:
Andrew Loh - Carmel IN, US
William Macias - Indianapolis IN, US
Simona Skerjanec - Pittstown NJ, US
William Macias - Indianapolis IN, US
Simona Skerjanec - Pittstown NJ, US
International Classification:
A61K031/405
US Classification:
514/419000
Abstract:
A novel method of treating and/or preventing sepsis.